ADHD medications offer promise in managing menopausal brain fog
New review provides preliminary evidence that both stimulant (LDX) and non-stimulant (ATX) medications used to treat Attention-Deficit Hyperactivity Disorder (ADHD) can significantly improve self-reported executive function during the menopause transition